Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
45,497
archived clinical trials in
Breast Cancer

The PIONEER-0 Study of the Imagio Breast Imaging System
A Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists
Status: Enrolling
Updated:  1/16/2018
MD Anderson Cancer Center, Department of Radiology and Breast Imaging
mi
from
Houston, TX
The PIONEER-0 Study of the Imagio Breast Imaging System
A Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists
Status: Enrolling
Updated: 1/16/2018
MD Anderson Cancer Center, Department of Radiology and Breast Imaging
mi
from
Houston, TX
Click here to add this to my saved trials
The PIONEER-0 Study of the Imagio Breast Imaging System
A Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists
Status: Enrolling
Updated:  1/16/2018
Univ. Texas Health Science Center at San Antontio, Breast Imaging Center at the Cancer Therapy Research Center
mi
from
San Antonio, TX
The PIONEER-0 Study of the Imagio Breast Imaging System
A Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists
Status: Enrolling
Updated: 1/16/2018
Univ. Texas Health Science Center at San Antontio, Breast Imaging Center at the Cancer Therapy Research Center
mi
from
San Antonio, TX
Click here to add this to my saved trials
The PIONEER-0 Study of the Imagio Breast Imaging System
A Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists
Status: Enrolling
Updated:  1/16/2018
Radnet (Temecula)
mi
from
Murrieta, CA
The PIONEER-0 Study of the Imagio Breast Imaging System
A Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists
Status: Enrolling
Updated: 1/16/2018
Radnet (Temecula)
mi
from
Murrieta, CA
Click here to add this to my saved trials
The PIONEER-0 Study of the Imagio Breast Imaging System
A Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists
Status: Enrolling
Updated:  1/16/2018
Sally Jobe
mi
from
Englewood, CO
The PIONEER-0 Study of the Imagio Breast Imaging System
A Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists
Status: Enrolling
Updated: 1/16/2018
Sally Jobe
mi
from
Englewood, CO
Click here to add this to my saved trials
The PIONEER-0 Study of the Imagio Breast Imaging System
A Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists
Status: Enrolling
Updated:  1/16/2018
Yale University
mi
from
New Haven, CT
The PIONEER-0 Study of the Imagio Breast Imaging System
A Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists
Status: Enrolling
Updated: 1/16/2018
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
The PIONEER-0 Study of the Imagio Breast Imaging System
A Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists
Status: Enrolling
Updated:  1/16/2018
Boca Raton Regional Hospital
mi
from
Boca Raton, FL
The PIONEER-0 Study of the Imagio Breast Imaging System
A Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists
Status: Enrolling
Updated: 1/16/2018
Boca Raton Regional Hospital
mi
from
Boca Raton, FL
Click here to add this to my saved trials
The PIONEER-0 Study of the Imagio Breast Imaging System
A Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists
Status: Enrolling
Updated:  1/16/2018
Breast Care Atlanta
mi
from
Atlanta, GA
The PIONEER-0 Study of the Imagio Breast Imaging System
A Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists
Status: Enrolling
Updated: 1/16/2018
Breast Care Atlanta
mi
from
Atlanta, GA
Click here to add this to my saved trials
The PIONEER-0 Study of the Imagio Breast Imaging System
A Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists
Status: Enrolling
Updated:  1/16/2018
Northwestern University
mi
from
Chicago, IL
The PIONEER-0 Study of the Imagio Breast Imaging System
A Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists
Status: Enrolling
Updated: 1/16/2018
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
The PIONEER-0 Study of the Imagio Breast Imaging System
A Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists
Status: Enrolling
Updated:  1/16/2018
New York-Presbyterian Hospital
mi
from
New York, NY
The PIONEER-0 Study of the Imagio Breast Imaging System
A Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists
Status: Enrolling
Updated: 1/16/2018
New York-Presbyterian Hospital
mi
from
New York, NY
Click here to add this to my saved trials
The PIONEER-0 Study of the Imagio Breast Imaging System
A Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists
Status: Enrolling
Updated:  1/16/2018
Elizabeth Wende Breast Care
mi
from
Rochester, NY
The PIONEER-0 Study of the Imagio Breast Imaging System
A Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists
Status: Enrolling
Updated: 1/16/2018
Elizabeth Wende Breast Care
mi
from
Rochester, NY
Click here to add this to my saved trials
The PIONEER-0 Study of the Imagio Breast Imaging System
A Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists
Status: Enrolling
Updated:  1/16/2018
Solis Women's Health (North Carolina)
mi
from
Greensboro, NC
The PIONEER-0 Study of the Imagio Breast Imaging System
A Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists
Status: Enrolling
Updated: 1/16/2018
Solis Women's Health (North Carolina)
mi
from
Greensboro, NC
Click here to add this to my saved trials
The PIONEER-0 Study of the Imagio Breast Imaging System
A Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists
Status: Enrolling
Updated:  1/16/2018
Weinstein Imaging Associates
mi
from
Pittsburgh, PA
The PIONEER-0 Study of the Imagio Breast Imaging System
A Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists
Status: Enrolling
Updated: 1/16/2018
Weinstein Imaging Associates
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
The PIONEER-0 Study of the Imagio Breast Imaging System
A Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists
Status: Enrolling
Updated:  1/16/2018
Austin Radiological Association
mi
from
Austin, TX
The PIONEER-0 Study of the Imagio Breast Imaging System
A Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists
Status: Enrolling
Updated: 1/16/2018
Austin Radiological Association
mi
from
Austin, TX
Click here to add this to my saved trials
The PIONEER-0 Study of the Imagio Breast Imaging System
A Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists
Status: Enrolling
Updated:  1/16/2018
Solis Women's Health
mi
from
Plano, TX
The PIONEER-0 Study of the Imagio Breast Imaging System
A Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists
Status: Enrolling
Updated: 1/16/2018
Solis Women's Health
mi
from
Plano, TX
Click here to add this to my saved trials
Neoadjuvant Carboplatin, Weekly Abraxane and Trastuzumab in HER2+ Breast Cancer
BrUOG-BR-211B q3week Carboplatin With Weekly Abraxane and Trastuzumab As Neoadjuvant Therapy in Resectable and Unresectable HER2+ (Stage IIa-IIIb) Breast Cancer
Status: Enrolling
Updated:  1/17/2018
City of Hope
mi
from
Duarte, CA
Neoadjuvant Carboplatin, Weekly Abraxane and Trastuzumab in HER2+ Breast Cancer
BrUOG-BR-211B q3week Carboplatin With Weekly Abraxane and Trastuzumab As Neoadjuvant Therapy in Resectable and Unresectable HER2+ (Stage IIa-IIIb) Breast Cancer
Status: Enrolling
Updated: 1/17/2018
City of Hope
mi
from
Duarte, CA
Click here to add this to my saved trials
Neoadjuvant Carboplatin, Weekly Abraxane and Trastuzumab in HER2+ Breast Cancer
BrUOG-BR-211B q3week Carboplatin With Weekly Abraxane and Trastuzumab As Neoadjuvant Therapy in Resectable and Unresectable HER2+ (Stage IIa-IIIb) Breast Cancer
Status: Enrolling
Updated:  1/17/2018
Yale Smilow Cancer Center
mi
from
New Haven, CT
Neoadjuvant Carboplatin, Weekly Abraxane and Trastuzumab in HER2+ Breast Cancer
BrUOG-BR-211B q3week Carboplatin With Weekly Abraxane and Trastuzumab As Neoadjuvant Therapy in Resectable and Unresectable HER2+ (Stage IIa-IIIb) Breast Cancer
Status: Enrolling
Updated: 1/17/2018
Yale Smilow Cancer Center
mi
from
New Haven, CT
Click here to add this to my saved trials
Neoadjuvant Carboplatin, Weekly Abraxane and Trastuzumab in HER2+ Breast Cancer
BrUOG-BR-211B q3week Carboplatin With Weekly Abraxane and Trastuzumab As Neoadjuvant Therapy in Resectable and Unresectable HER2+ (Stage IIa-IIIb) Breast Cancer
Status: Enrolling
Updated:  1/17/2018
Women and Infants Hospital
mi
from
Providence, RI
Neoadjuvant Carboplatin, Weekly Abraxane and Trastuzumab in HER2+ Breast Cancer
BrUOG-BR-211B q3week Carboplatin With Weekly Abraxane and Trastuzumab As Neoadjuvant Therapy in Resectable and Unresectable HER2+ (Stage IIa-IIIb) Breast Cancer
Status: Enrolling
Updated: 1/17/2018
Women and Infants Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Neoadjuvant Carboplatin, Weekly Abraxane and Trastuzumab in HER2+ Breast Cancer
BrUOG-BR-211B q3week Carboplatin With Weekly Abraxane and Trastuzumab As Neoadjuvant Therapy in Resectable and Unresectable HER2+ (Stage IIa-IIIb) Breast Cancer
Status: Enrolling
Updated:  1/17/2018
Roger Williams Medical Center
mi
from
Providence, RI
Neoadjuvant Carboplatin, Weekly Abraxane and Trastuzumab in HER2+ Breast Cancer
BrUOG-BR-211B q3week Carboplatin With Weekly Abraxane and Trastuzumab As Neoadjuvant Therapy in Resectable and Unresectable HER2+ (Stage IIa-IIIb) Breast Cancer
Status: Enrolling
Updated: 1/17/2018
Roger Williams Medical Center
mi
from
Providence, RI
Click here to add this to my saved trials
Neoadjuvant Carboplatin, Weekly Abraxane and Trastuzumab in HER2+ Breast Cancer
BrUOG-BR-211B q3week Carboplatin With Weekly Abraxane and Trastuzumab As Neoadjuvant Therapy in Resectable and Unresectable HER2+ (Stage IIa-IIIb) Breast Cancer
Status: Enrolling
Updated:  1/17/2018
Rhode Island and The Miriam Hospital
mi
from
Providence, RI
Neoadjuvant Carboplatin, Weekly Abraxane and Trastuzumab in HER2+ Breast Cancer
BrUOG-BR-211B q3week Carboplatin With Weekly Abraxane and Trastuzumab As Neoadjuvant Therapy in Resectable and Unresectable HER2+ (Stage IIa-IIIb) Breast Cancer
Status: Enrolling
Updated: 1/17/2018
Rhode Island and The Miriam Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Rx for Better Breast Health
Prescription for Better Breast Health
Status: Enrolling
Updated:  1/18/2018
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Rx for Better Breast Health
Prescription for Better Breast Health
Status: Enrolling
Updated: 1/18/2018
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
TEEL Study- Phase 1 Tamoxifen and Ribociclib (LEE011) in Advanced ER+ (HER2 Negative) Breast Cancer
The TEEL Study: A Phase I Trial of Tamoxifen With Ribociclib (LEE011) in Adult Patients With Advanced ER+ (HER2 Negative) Breast Cancer
Status: Enrolling
Updated:  1/18/2018
H. Lee Moffitt Cancer Center & Research Institute
mi
from
Tampa, FL
TEEL Study- Phase 1 Tamoxifen and Ribociclib (LEE011) in Advanced ER+ (HER2 Negative) Breast Cancer
The TEEL Study: A Phase I Trial of Tamoxifen With Ribociclib (LEE011) in Adult Patients With Advanced ER+ (HER2 Negative) Breast Cancer
Status: Enrolling
Updated: 1/18/2018
H. Lee Moffitt Cancer Center & Research Institute
mi
from
Tampa, FL
Click here to add this to my saved trials
Bioequivalency Study of Anastrozole 1 mg Under Fed Conditions
A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Anastrozole 1 mg Tablets Under Fed Conditions
Status: Enrolling
Updated:  1/19/2018
Bio-Kinetic Clinical Applications, Inc.
mi
from
Springfield, MO
Bioequivalency Study of Anastrozole 1 mg Under Fed Conditions
A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Anastrozole 1 mg Tablets Under Fed Conditions
Status: Enrolling
Updated: 1/19/2018
Bio-Kinetic Clinical Applications, Inc.
mi
from
Springfield, MO
Click here to add this to my saved trials
Bioequivalency Study of Anastrozole 1 mg Under Fasted Conditions
A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Anastrozole 1 mg Tablets Under Fasting Conditions
Status: Enrolling
Updated:  1/19/2018
Bio-Kinetic Clinical Applications, Inc.
mi
from
Springfield, MO
Bioequivalency Study of Anastrozole 1 mg Under Fasted Conditions
A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Anastrozole 1 mg Tablets Under Fasting Conditions
Status: Enrolling
Updated: 1/19/2018
Bio-Kinetic Clinical Applications, Inc.
mi
from
Springfield, MO
Click here to add this to my saved trials
Bioequivalency Study of Exemestane 25 mg Tablet Under Fasted Conditions
A Single Dose, 2-Period, 2-Treatment, 2-Way Bioequivalency Study of Exemestane 25 mg Tablets Under Fasting Conditions
Status: Enrolling
Updated:  1/19/2018
BioKinetic Clinical Applications, Inc.
mi
from
Springfield, MO
Bioequivalency Study of Exemestane 25 mg Tablet Under Fasted Conditions
A Single Dose, 2-Period, 2-Treatment, 2-Way Bioequivalency Study of Exemestane 25 mg Tablets Under Fasting Conditions
Status: Enrolling
Updated: 1/19/2018
BioKinetic Clinical Applications, Inc.
mi
from
Springfield, MO
Click here to add this to my saved trials
Bioequivalency Study of Exemestane 25 mg Tablet Under Fed Conditions
A Single Dose, 2-Period, 2-Treatment, 2-Way Bioequivalency Study of Exemestane 25 mg Tablets Under Fed Conditions
Status: Enrolling
Updated:  1/19/2018
Bio-Kinetic Clinical Applications, Inc.
mi
from
Springfield, MO
Bioequivalency Study of Exemestane 25 mg Tablet Under Fed Conditions
A Single Dose, 2-Period, 2-Treatment, 2-Way Bioequivalency Study of Exemestane 25 mg Tablets Under Fed Conditions
Status: Enrolling
Updated: 1/19/2018
Bio-Kinetic Clinical Applications, Inc.
mi
from
Springfield, MO
Click here to add this to my saved trials
Pilot Bioequivalency Study of Exemestane 25 mg Tablet Under Fasted Conditions
A Pilot Single Dose, 2-Period, 2-Treatment, 2-Way Bioequivalency Study of Exemestane 25 mg Tablets Under Fasting Conditions
Status: Enrolling
Updated:  1/19/2018
BioKinetic Clinical Applications, Inc.
mi
from
Springfield, MO
Pilot Bioequivalency Study of Exemestane 25 mg Tablet Under Fasted Conditions
A Pilot Single Dose, 2-Period, 2-Treatment, 2-Way Bioequivalency Study of Exemestane 25 mg Tablets Under Fasting Conditions
Status: Enrolling
Updated: 1/19/2018
BioKinetic Clinical Applications, Inc.
mi
from
Springfield, MO
Click here to add this to my saved trials
Bioequivalency Study of Letrozole 2.5 mg Tablets Under Fed Conditions
A Single Dose, 2-Period, 2-Treatment 2-Way Crossover Bioequivalency Study of Letrozole Tablets Under Fed Conditions
Status: Enrolling
Updated:  1/19/2018
PRACS Institute, Ltd.
mi
from
Fargo, ND
Bioequivalency Study of Letrozole 2.5 mg Tablets Under Fed Conditions
A Single Dose, 2-Period, 2-Treatment 2-Way Crossover Bioequivalency Study of Letrozole Tablets Under Fed Conditions
Status: Enrolling
Updated: 1/19/2018
PRACS Institute, Ltd.
mi
from
Fargo, ND
Click here to add this to my saved trials
Bioequivalency Study of Letrozole 2.5 mg Tablets Under Fasted Conditions
A Single Dose, 2-Period, 2-Treatment 2-Way Crossover Bioequivalency Study of Letrozole Tablets Under Fasted Conditions
Status: Enrolling
Updated:  1/19/2018
PRACS Institute, Ltd.
mi
from
Fargo, ND
Bioequivalency Study of Letrozole 2.5 mg Tablets Under Fasted Conditions
A Single Dose, 2-Period, 2-Treatment 2-Way Crossover Bioequivalency Study of Letrozole Tablets Under Fasted Conditions
Status: Enrolling
Updated: 1/19/2018
PRACS Institute, Ltd.
mi
from
Fargo, ND
Click here to add this to my saved trials
Breath Test for Women Receiving Tamoxifen in the Prevention or Treatment of Breast Cancer
¹³C - Dextromethorphan (DM) Breath Test for Determination of CYP2D6 Enzyme Activity in Patients Receiving Tamoxifen
Status: Enrolling
Updated:  1/22/2018
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Breath Test for Women Receiving Tamoxifen in the Prevention or Treatment of Breast Cancer
¹³C - Dextromethorphan (DM) Breath Test for Determination of CYP2D6 Enzyme Activity in Patients Receiving Tamoxifen
Status: Enrolling
Updated: 1/22/2018
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Breath Test for Women Receiving Tamoxifen in the Prevention or Treatment of Breast Cancer
¹³C - Dextromethorphan (DM) Breath Test for Determination of CYP2D6 Enzyme Activity in Patients Receiving Tamoxifen
Status: Enrolling
Updated:  1/22/2018
The Mayo Clinic
mi
from
Rochester, MN
Breath Test for Women Receiving Tamoxifen in the Prevention or Treatment of Breast Cancer
¹³C - Dextromethorphan (DM) Breath Test for Determination of CYP2D6 Enzyme Activity in Patients Receiving Tamoxifen
Status: Enrolling
Updated: 1/22/2018
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Technology and Navigation to Improve Survivorship Care
Integrating Technology and Navigation to Improve Survivorship Care in Underserved Populations
Status: Enrolling
Updated:  1/22/2018
Lyndon B Johnson Hospital
mi
from
Houston, TX
Technology and Navigation to Improve Survivorship Care
Integrating Technology and Navigation to Improve Survivorship Care in Underserved Populations
Status: Enrolling
Updated: 1/22/2018
Lyndon B Johnson Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Capecitabine With Digoxin for Metastatic Breast Cancer
Metronomic Capecitabine With Digoxin for Metastatic Breast Cancer Progressing After Anthracycline and Taxane Treatment
Status: Enrolling
Updated:  1/22/2018
Western Regional Medical Center, Inc
mi
from
Goodyear, AZ
Capecitabine With Digoxin for Metastatic Breast Cancer
Metronomic Capecitabine With Digoxin for Metastatic Breast Cancer Progressing After Anthracycline and Taxane Treatment
Status: Enrolling
Updated: 1/22/2018
Western Regional Medical Center, Inc
mi
from
Goodyear, AZ
Click here to add this to my saved trials
A Study of Vantictumab (OMP-18R5) in Combination With Paclitaxel in Locally Recurrent or Metastatic Breast Cancer
A Phase 1b Dose Escalation Study of Vantictumab (OMP-18R5) in Combination With Paclitaxel in Patients With Locally Recurrent or Metastatic Breast Cancer
Status: Enrolling
Updated:  1/22/2018
Cedars-Sinai Medical Center/Samuel Oschin Comprehensive Cancer institute
mi
from
Los Angeles, CA
A Study of Vantictumab (OMP-18R5) in Combination With Paclitaxel in Locally Recurrent or Metastatic Breast Cancer
A Phase 1b Dose Escalation Study of Vantictumab (OMP-18R5) in Combination With Paclitaxel in Patients With Locally Recurrent or Metastatic Breast Cancer
Status: Enrolling
Updated: 1/22/2018
Cedars-Sinai Medical Center/Samuel Oschin Comprehensive Cancer institute
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study of Vantictumab (OMP-18R5) in Combination With Paclitaxel in Locally Recurrent or Metastatic Breast Cancer
A Phase 1b Dose Escalation Study of Vantictumab (OMP-18R5) in Combination With Paclitaxel in Patients With Locally Recurrent or Metastatic Breast Cancer
Status: Enrolling
Updated:  1/22/2018
University of Colorado Cancer Center
mi
from
Aurora, CO
A Study of Vantictumab (OMP-18R5) in Combination With Paclitaxel in Locally Recurrent or Metastatic Breast Cancer
A Phase 1b Dose Escalation Study of Vantictumab (OMP-18R5) in Combination With Paclitaxel in Patients With Locally Recurrent or Metastatic Breast Cancer
Status: Enrolling
Updated: 1/22/2018
University of Colorado Cancer Center
mi
from
Aurora, CO
Click here to add this to my saved trials
A Study of Vantictumab (OMP-18R5) in Combination With Paclitaxel in Locally Recurrent or Metastatic Breast Cancer
A Phase 1b Dose Escalation Study of Vantictumab (OMP-18R5) in Combination With Paclitaxel in Patients With Locally Recurrent or Metastatic Breast Cancer
Status: Enrolling
Updated:  1/22/2018
Texas Oncology-Baylor Charles A. Sammons Cancer Center
mi
from
Dallas, TX
A Study of Vantictumab (OMP-18R5) in Combination With Paclitaxel in Locally Recurrent or Metastatic Breast Cancer
A Phase 1b Dose Escalation Study of Vantictumab (OMP-18R5) in Combination With Paclitaxel in Patients With Locally Recurrent or Metastatic Breast Cancer
Status: Enrolling
Updated: 1/22/2018
Texas Oncology-Baylor Charles A. Sammons Cancer Center
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study of Vantictumab (OMP-18R5) in Combination With Paclitaxel in Locally Recurrent or Metastatic Breast Cancer
A Phase 1b Dose Escalation Study of Vantictumab (OMP-18R5) in Combination With Paclitaxel in Patients With Locally Recurrent or Metastatic Breast Cancer
Status: Enrolling
Updated:  1/22/2018
Texas Oncology-Tyler
mi
from
Tyler, TX
A Study of Vantictumab (OMP-18R5) in Combination With Paclitaxel in Locally Recurrent or Metastatic Breast Cancer
A Phase 1b Dose Escalation Study of Vantictumab (OMP-18R5) in Combination With Paclitaxel in Patients With Locally Recurrent or Metastatic Breast Cancer
Status: Enrolling
Updated: 1/22/2018
Texas Oncology-Tyler
mi
from
Tyler, TX
Click here to add this to my saved trials
Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy
Intra-mammary Distribution of Transdermal Telapristone Versus Oral Telapristone: A Randomized Window Trial in Women Undergoing Mastectomy
Status: Enrolling
Updated:  1/22/2018
Cedars-Sinai Medical Center
mi
from
West Hollywood, CA
Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy
Intra-mammary Distribution of Transdermal Telapristone Versus Oral Telapristone: A Randomized Window Trial in Women Undergoing Mastectomy
Status: Enrolling
Updated: 1/22/2018
Cedars-Sinai Medical Center
mi
from
West Hollywood, CA
Click here to add this to my saved trials
Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy
Intra-mammary Distribution of Transdermal Telapristone Versus Oral Telapristone: A Randomized Window Trial in Women Undergoing Mastectomy
Status: Enrolling
Updated:  1/22/2018
Northwestern University
mi
from
Chicago, IL
Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy
Intra-mammary Distribution of Transdermal Telapristone Versus Oral Telapristone: A Randomized Window Trial in Women Undergoing Mastectomy
Status: Enrolling
Updated: 1/22/2018
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy
Intra-mammary Distribution of Transdermal Telapristone Versus Oral Telapristone: A Randomized Window Trial in Women Undergoing Mastectomy
Status: Enrolling
Updated:  1/22/2018
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy
Intra-mammary Distribution of Transdermal Telapristone Versus Oral Telapristone: A Randomized Window Trial in Women Undergoing Mastectomy
Status: Enrolling
Updated: 1/22/2018
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Neoadjuvant Hormonal Therapy Combined With Chemoimmunotherapy
Neoadjuvant Hormonal Therapy Combined With Chemoimmunotherapy (Taxotere, Trastuzumab and Pertuzumab) in Patients With HER2-positive and ER-Positive Breast Cancer (NeoHTTP Study)
Status: Enrolling
Updated:  1/22/2018
Western Regional Medical Center, Inc
mi
from
Goodyear, AZ
Neoadjuvant Hormonal Therapy Combined With Chemoimmunotherapy
Neoadjuvant Hormonal Therapy Combined With Chemoimmunotherapy (Taxotere, Trastuzumab and Pertuzumab) in Patients With HER2-positive and ER-Positive Breast Cancer (NeoHTTP Study)
Status: Enrolling
Updated: 1/22/2018
Western Regional Medical Center, Inc
mi
from
Goodyear, AZ
Click here to add this to my saved trials
Use of the Contura™ Catheter in Intermediate-Risk, Pathological Stage 0, I, or II (Up to 3.0 cm) Breast Cancer Patients
Registry Study of the Contura™ Multi-Lumen Balloon (MLB) Applicator for Accelerated Partial Breast Irradiation in Intermediate-Risk, Pathological Stage 0, I, or II (Up to 3.0 cm) Breast Cancer Patients
Status: Enrolling
Updated:  1/23/2018
Cancer Center of Irvine
mi
from
Irvine, CA
Use of the Contura™ Catheter in Intermediate-Risk, Pathological Stage 0, I, or II (Up to 3.0 cm) Breast Cancer Patients
Registry Study of the Contura™ Multi-Lumen Balloon (MLB) Applicator for Accelerated Partial Breast Irradiation in Intermediate-Risk, Pathological Stage 0, I, or II (Up to 3.0 cm) Breast Cancer Patients
Status: Enrolling
Updated: 1/23/2018
Cancer Center of Irvine
mi
from
Irvine, CA
Click here to add this to my saved trials
Use of the Contura™ Catheter to Deliver Accelerated Partial Breast Irradiation to "Low-risk" Breast Cancer Patients
A Multi-Site, Prospective, Non-Randomized Study of the Contura™ Multi-Lumen Balloon (MLB) Catheter to Deliver Accelerated Partial Breast Irradiation: Analysis of Dosimetry, Local Tumor Control, Cosmetic Outcome, and Toxicity
Status: Enrolling
Updated:  1/23/2018
Cancer Center of Irvine
mi
from
Irvine, CA
Use of the Contura™ Catheter to Deliver Accelerated Partial Breast Irradiation to "Low-risk" Breast Cancer Patients
A Multi-Site, Prospective, Non-Randomized Study of the Contura™ Multi-Lumen Balloon (MLB) Catheter to Deliver Accelerated Partial Breast Irradiation: Analysis of Dosimetry, Local Tumor Control, Cosmetic Outcome, and Toxicity
Status: Enrolling
Updated: 1/23/2018
Cancer Center of Irvine
mi
from
Irvine, CA
Click here to add this to my saved trials
Phase Ib Trial of Two Folate Binding Protein Peptide Vaccines (E39 and J65) in Breast and Ovarian Cancer Patients
Phase Ib Trial of Two Folate Binding Protein (FBP) Peptide Vaccines (E39 and J65) in Breast and Ovarian Cancer Patients
Status: Enrolling
Updated:  1/23/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Phase Ib Trial of Two Folate Binding Protein Peptide Vaccines (E39 and J65) in Breast and Ovarian Cancer Patients
Phase Ib Trial of Two Folate Binding Protein (FBP) Peptide Vaccines (E39 and J65) in Breast and Ovarian Cancer Patients
Status: Enrolling
Updated: 1/23/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Home-Based Lymphedema Care Program (HBLCP) in Improving Lymphedema Self-Care in Head and Neck Cancer Survivors
Development and Pilot Testing of a Home-Based Program for Head and Neck Cancer Survivors With Lymphedema
Status: Enrolling
Updated:  1/23/2018
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Home-Based Lymphedema Care Program (HBLCP) in Improving Lymphedema Self-Care in Head and Neck Cancer Survivors
Development and Pilot Testing of a Home-Based Program for Head and Neck Cancer Survivors With Lymphedema
Status: Enrolling
Updated: 1/23/2018
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Concurrent Adjuvant Carboplatin and Accelerated Radiotherapy for Triple Negative Breast Cancer
Phase I-II Study of Concurrent Adjuvant Systemic Therapy and Accelerated Radiotherapy (Over 3 Weeks)
Status: Enrolling
Updated:  1/24/2018
NYU Cancer Center
mi
from
New York, NY
Concurrent Adjuvant Carboplatin and Accelerated Radiotherapy for Triple Negative Breast Cancer
Phase I-II Study of Concurrent Adjuvant Systemic Therapy and Accelerated Radiotherapy (Over 3 Weeks)
Status: Enrolling
Updated: 1/24/2018
NYU Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Mobile Phone Multimedia Messaging Intervention for Breast Cancer Screening
Mobile Phone Multimedia Messaging Intervention for Breast Cancer Screening: Intervention Phase
Status: Enrolling
Updated:  1/24/2018
University of Minnesota, Masonic Cancer Center
mi
from
Minneapolis, MN
Mobile Phone Multimedia Messaging Intervention for Breast Cancer Screening
Mobile Phone Multimedia Messaging Intervention for Breast Cancer Screening: Intervention Phase
Status: Enrolling
Updated: 1/24/2018
University of Minnesota, Masonic Cancer Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A Home-Based Study to Enhance Activity in Breast Cancer Survivors
A Home-Based Study to Enhance Activity in Breast Cancer Survivors
Status: Enrolling
Updated:  1/25/2018
Baystate Medical Center
mi
from
Springfield, MA
A Home-Based Study to Enhance Activity in Breast Cancer Survivors
A Home-Based Study to Enhance Activity in Breast Cancer Survivors
Status: Enrolling
Updated: 1/25/2018
Baystate Medical Center
mi
from
Springfield, MA
Click here to add this to my saved trials
Measurements of Breast Tissue Optical Properties
Measurements of Breast Tissue Optical Properties
Status: Enrolling
Updated:  1/26/2018
Pacific Breast Care Medical Clinic
mi
from
Costa Mesa, CA
Measurements of Breast Tissue Optical Properties
Measurements of Breast Tissue Optical Properties
Status: Enrolling
Updated: 1/26/2018
Pacific Breast Care Medical Clinic
mi
from
Costa Mesa, CA
Click here to add this to my saved trials
Measurements of Breast Tissue Optical Properties
Measurements of Breast Tissue Optical Properties
Status: Enrolling
Updated:  1/26/2018
Beckman Laser Institute University of California Irvine
mi
from
Irvine, CA
Measurements of Breast Tissue Optical Properties
Measurements of Breast Tissue Optical Properties
Status: Enrolling
Updated: 1/26/2018
Beckman Laser Institute University of California Irvine
mi
from
Irvine, CA
Click here to add this to my saved trials
Measurements of Breast Tissue Optical Properties
Measurements of Breast Tissue Optical Properties
Status: Enrolling
Updated:  1/26/2018
UCSD Regional Fertility Center
mi
from
La Jolla San Diego, CA
Measurements of Breast Tissue Optical Properties
Measurements of Breast Tissue Optical Properties
Status: Enrolling
Updated: 1/26/2018
UCSD Regional Fertility Center
mi
from
La Jolla San Diego, CA
Click here to add this to my saved trials